Search research articles
Contact Us
Filters
Showing results (111-120 of 179) with videos related to
Page
of 18
Sort By:
Blood
|
February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
Blood
|
April 30, 2015
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma
Thomas E Witzig, Craig Reeder, Jing Jing Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma
Jane N Winter, David J Inwards, Stewart Spies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study
Grzegorz S Nowakowski, Betsy LaPlant, William R Macon, et al.
Blood Cancer Journal
|
August 3, 2018
History of autoimmune conditions and lymphoma prognosis
Geffen Kleinstern, Matthew J Maurer, Mark Liebow, et al.
Leukemia & Lymphoma
|
October 21, 2010
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
British Journal of Haematology
|
May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Narendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 14, 2011
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR
Gregory A Hale, Smriti Shrestha, Jennifer Le-Rademacher, et al.
Leukemia & Lymphoma
|
January 21, 2003
Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator
Mark R Litzow, Panagiotis D Repoussis, Georgene Schroeder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 28, 2012
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization
Ivana N M Micallef, Shirshendu Sinha, Dennis A Gastineau, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 179) with videos related to
Sort By:
Page
of 18
Blood
|
February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
Blood
|
April 30, 2015
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma
Thomas E Witzig, Craig Reeder, Jing Jing Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2009
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma
Jane N Winter, David J Inwards, Stewart Spies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study
Grzegorz S Nowakowski, Betsy LaPlant, William R Macon, et al.
Blood Cancer Journal
|
August 3, 2018
History of autoimmune conditions and lymphoma prognosis
Geffen Kleinstern, Matthew J Maurer, Mark Liebow, et al.
Leukemia & Lymphoma
|
October 21, 2010
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
British Journal of Haematology
|
May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Narendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 14, 2011
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR
Gregory A Hale, Smriti Shrestha, Jennifer Le-Rademacher, et al.
Leukemia & Lymphoma
|
January 21, 2003
Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator
Mark R Litzow, Panagiotis D Repoussis, Georgene Schroeder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 28, 2012
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization
Ivana N M Micallef, Shirshendu Sinha, Dennis A Gastineau, et al.
Page
of 18